The World of Health & Medicine News

WHO launches bold push to raise health taxes and save millions of lives

WHO launches bold push to raise health taxes and save millions of lives

The “3 by 35” Initiative targets tobacco, alcohol, and sugary drinks to cut deaths and boost health and development funding

The World Health Organization (WHO) today has launched a major new initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50% by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue. The “3 by 35” Initiative comes at a time when health systems are under enormous strain from rising noncommunicable diseases (NCDs), shrinking development aid and growing public debt.

The consumption of tobacco, alcohol, and sugary drinks are fueling the NCD epidemic. NCDs, including heart disease, cancer, and diabetes, account for over 75% of all deaths worldwide. A recent report shows that a one-time 50% price increase on these products could prevent 50 million premature deaths over the next 50 years.

“Health taxes are one of the most efficient tools we have,” said Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO. “They cut the consumption of harmful products and create revenue governments can reinvest in health care, education, and social protection. It’s time to act.”

The Initiative has an ambitious but achievable goal of raising US$1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50% on average, showing that large-scale change is possible.

From Colombia to South Africa, governments that have introduced health taxes have seen reduced consumption and increased revenue. Yet many countries continue to provide tax incentives to unhealthy industries, including tobacco. Moreover, long-term investment agreements with industry that restrict tobacco tax increases can further undermine national health goals. WHO encourages governments to review and avoid such exemptions to support effective tobacco control and protect public health.

Strong collaboration is at the heart of the “3 by 35” Initiative’s success. Led by WHO, the Initiative brings together a powerful group of global partners to help countries put health taxes into action. These organizations offer a mix of technical know-how, policy advice, and real-world experience. By working together, they aim to raise awareness about the benefits of health taxes and support efforts at the national level.

Many countries have expressed interest in transitioning toward more self-reliant, domestically funded health systems and are turning to WHO for guidance.

The “3 by 35” Initiative introduces key action areas to help countries, pairing proven health policies with best practices on implementation. These include direct support for country-led reforms with the following goals in mind:

  1. Cutting harmful consumption by reducing affordability;

Increase or introduce excise taxes on tobacco, alcohol, and sugary drinks to raise prices and reduce consumption, cutting future health costs and preventable deaths.

  1. Raising revenue to fund health and development;

Mobilize domestic public resources to fund essential health and development programmes, including universal health coverage.

  1. Building broad political support across ministries, civil society, and academia;

Strengthen multisectoral alliances by engaging ministries of finance and health, parliamentarians, civil society, and researchers to design and implement effective policies.

WHO is calling on countries, civil society, and development partners to support the “3 by 35” Initiative and commit to smarter, fairer taxation that protects health and accelerates progress toward the Sustainable Development Goals.

spot_img

Explore more

spot_img

US CDC accepts ousted vaccine panel’s recommendations for RSV, meningococcal shots

US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a...

NATO fund backs biotech startup in push to counter biological threats

NATO fund backs biotech startup in push to counter biological threats The NATO Innovation Fund has made its first investment in a biotechnology company, it...

It’s too easy to make AI chatbots lie about health information,...

It’s too easy to make AI chatbots lie about health information, study finds Well-known AI chatbots can be configured to routinely answer health queries with...

Innogen, Other Chinese Pharmas to Cause Weight-Loss Drug Price Plunge

Innogen, Other Chinese Pharmas to Cause Weight-Loss Drug Price Plunge Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug...

China Approves First Homegrown GLP-1 Obesity Drug, Challenging Global Giants

China Approves First Homegrown GLP-1 Obesity Drug, Challenging Global Giants Chinese pharmaceutical company Hangzhou Jiuyuan Gene Engineering has received preliminary approval in China for Maibulin, an...

Should you drink ice water in hot weather?

Should you drink ice water in hot weather? Things are hotting up across the U.S. — this past week saw hundreds of record highs broken from...

Exclusive-USAID Cancelled Rape Survivor Kits for Congo as Conflict Erupted

Exclusive-USAID Cancelled Rape Survivor Kits for Congo as Conflict Erupted U.S. President Donald Trump's administration cancelled a major contract to supply emergency kits for rape...

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR...

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis  Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European...